期刊文献+

Survivin及其异变体、P53和MDM2在柔红霉素诱导Jurkat细胞凋亡中的变化 被引量:1

Change of Survivin and its splice variants,P53,MDM2 in the apoptosis of Jurkat cell induced by Daunorubicin
原文传递
导出
摘要 目的:探讨Survivin及其异变体(Survivin-2B和Survivin-△Ex3)、P53和MDM2在柔红霉素(DNR)诱导白血病Jurkat细胞凋亡中的变化。方法:DNR设0.1mg/L、1mg/L、10mg/L 3个浓度,作用Jurkat细胞12h、24h后,用RT-PCR方法检测Survivin、Survivin-2B、Survivin-△Ex3、P53及MDM2基因的mRNA表达变化,用Western-blot方法检测同样条件下Survivin、P53及MDM2蛋白表达的变化。结果:在mRNA水平,DNR抑制Survivin、Survivin-△Ex3表达,促进Survivin-2B、P53表达,具有时间与浓度依赖性(P<0.05);DNR抑制MDM2表达表现出时间依赖性和不完全浓度依赖性(P<0.05)。在蛋白水平,DNR以时间和浓度依赖方式抑制Survivin、MDM2表达,促进P53表达(P<0.05)。结论:DNR通过下调Survivin、Survivin-△Ex3、MDM2表达,上调Survivin-2B、P53表达,从而诱导Jurkat细胞凋亡,且呈时间和浓度依赖性。通过干扰Survivin、Survivin-△Ex3及MDM2的表达,有望提高白血病细胞对DNR的敏感性,从而提高临床缓解率及预后。 Objective:To investigate the change of Survivin and its splice variants(Survivin-2B and Survivin-△Ex3),P53,MDM2 in the apoptosis of Jurkat cell induced by Daunorubicin(DNR). Method:Jurkat cell was treated by DNR with different concentrations(0.1 mg/L,1 mg/L,10 mg/L) for 12 h and 24 h.Survivin,Survivin-2B,Survivin-△Ex3,P53 and MDM2 mRNA were measured by RT-PCR.The expression of Survivin,P53,MDM2 proteins were detected by Western-blot. Result:The mRNA expressions of Survivin and Survivin-△Ex3 were inhibited by DNR in time-and dose-dependent manners,but the mRNA expressions of Survivin-2B and P53 were improved(P0.05).The mRNA expression of MDM2 was inhibited by DNR in time-dependent manner and not all dose-dependent manner(P0.05).Survivin and MDM2 proteins decreased by DNR in time-and dose-dependent manners,but P53 protein increased(P0.05). Conclusion:DNR induces the apoptosis of Jurkat cell not only through inhibiting the expressions of Survivin,Survivin-△Ex3 and MDM2 but also improving the expressions of Survivin-2B and P53 in time-and dose-dependent manners.Leukemia cells may become susceptive to DNR via disturbing the expressions of Survivin,Survivin-△Ex3 and MDM2,thereby improving clinical remission rate and prognosis.
出处 《临床血液学杂志》 CAS 2013年第4期482-484,487,共4页 Journal of Clinical Hematology
关键词 Survivin及其异变体 MDM2 P53 JURKAT细胞 柔红霉素 Survivin and splice variants MDM2 P53 Jurkat cell Daunorubicin
  • 相关文献

参考文献7

  • 1SAH N K, KHAN Z, KHAN G J, et al. Structural, functional and therapeutic biology of survivin [J]. Cancer Lett, 2006,244 : 164 - 171. 被引量:1
  • 2侯燕,胡群,何学琴.Survivin在柔红霉素与长春新碱诱导白血病细胞凋亡中的作用[J].中国实用儿科杂志,2007,22(10):767-769. 被引量:1
  • 3胡群,侯燕,刘爱国.Survivin在柔红霉素诱导白血病细胞凋亡作用机制中的研究[J].临床血液学杂志,2008,21(6):597-599. 被引量:3
  • 4ZHENG W Y,KANG Y Y,LI L F,et al. Levels of ef- fectiveness of gene therapies targeting survivin and its splice variants in human breast cancer cells[J]. Drug Discov Ther,2011,5:293-298. 被引量:1
  • 5VANDGHANOONI S, ESKANDANI M, MONTAZ- ERI V, et al. Survivin-deltaEx3.. a novel biomarker for diagnosis of papillary thyroid carcinom[J]. J Cancer Res Ther,2011,7 ,, 325- 330. 被引量:1
  • 6CHO G S, AHN T S,JEONG D, et al. Expression of the Survivin-2B splice variant related to the progres- sion of colorectal carcinoma[J]. J Korean Surg Soc, 2011,80:404-411. 被引量:1
  • 7MARIONI G, AGOSTINI M, BEDIN C, et al. Survivin and laryngeal carcinoma prognosis ,, nuclear localization and expression of splice variants[J]. Histopathology, 2012,61:247-256. 被引量:1

二级参考文献15

  • 1刘仲萍,伍晓菲,游泳,陈智超.三氧化二砷对K562细胞生长及Ki-67和Survivin表达的影响[J].临床血液学杂志,2004,17(4):221-223. 被引量:1
  • 2李中东,齐振华,陈方平.Survivin与恶性血液病[J].临床血液学杂志,2004,17(6):362-365. 被引量:2
  • 3侯燕,胡群,刘爱国,张柳清,蒋艳,陶红芳,胡迎.Survivin在儿童急性白血病中的表达和P53的相关性及其临床意义[J].中国实用儿科杂志,2005,20(5):283-285. 被引量:6
  • 4AMBROSINI G, ADIDA C, ALTIERI D C. A novel anti apoptosis gene,survivin,expression in cancer and lymphoma[J]. Nat Med, 1997,3 :917-921. 被引量:1
  • 5DOHI T, BELTRAMI E, WALL N R, et al. Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis[J]. J Clin Invest, 2004,114 : 1117 -- 1127. 被引量:1
  • 6IDENOUE S, HIROHASHI Y, TORIGOE T, et al. A potent immunogenic general cancer vaccine that tar gets survivin, an inhibitor of apoptosis proteins [J]. Clin Cancer Res, 2005,11 : 1474-- 1482. 被引量:1
  • 7BLANC-BRUDE O P,MESRI M,WALL N R,et al. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor associated angiogenesis[J]. Clin Cancer Res,2003,9:2683--2692. 被引量:1
  • 8O'DRISCOLL L, I.INEHAN R, CLYNES M. Survivin: role in normal cells and in pathological conditions[J]. Curr Cancer Drug Targets, 2003,3: 131- 152. 被引量:1
  • 9SUZUKI A, HAYASHIDA M, ITO T, et al. Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16 and Cdk2/cyclin E complex activation [J]. Oncogene, 2000,19 : 3225 - 3234. 被引量:1
  • 10Ambrosini G,Adida C,Altieri DC.A novel anti-apoptosis gene,survivin,expression in cancer and lymphoma[J].Nat Med,1997,3(8):917-921. 被引量:1

共引文献2

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部